EUVIMEDEUVIMED entdecken
Crossref

Intracavernous Stem Cell Injection for Erectile Dysfunction: Safety and Efficacy Review

Ahmad Sulaiman Lubis, Fadhli Rizal Makarim, Pradipta Hadyan Aldiosta

International Journal of Cell and Biomedical Science · 2023

DOI: 10.59278/cbs.v2i4.28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cell and Biomedical Science, 2023. Verfasst von Ahmad Sulaiman Lubis und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Erectile dysfunction is a common condition in men characterized by the inability to maintain an erectile state. Current treatment using phosphodiesterase-5 inhibitors treatment may leave significant side effects and effectivity problems in some patients. The use of stem cell transplantation in erectile dysfunction has been emerging as a replacement therapy for erectile dysfunction. The effectiveness of stem cell therapy for the treatment of erectile dysfunction has been investigated in several animal studies and one clinical trial in humans. The intracavernous injection is one of the methods to deliver stem cell treatment for erectile dysfunction besides intravenous and intraperitoneal. It was believed to improve erectile function by promoting cavernosal tissue regeneration, vascularization, and smooth muscle relaxation. However, the intracavernous injection of stem cells for erectile dysfunction treatment in clinical settings requires further investigation since its long-term efficacy and safety concerns regarding swelling, priapism, and fibrous plaque.

Objective

This review aims to summarize the available evidence on the safety and efficacy of intracavernous stem cell injection for erectile dysfunction treatment in clinical studies only from PubMed.

Conclusion

In conclusion, while the available evidence suggests that intracavernous stem cell injection is considered safe and effective for the treatment of erectile dysfunction, further large-scale clinical studies are needed to determine its long-term safety, efficacy, and optimal dosing regimens.

Zitieren

APA

Lubis, A. S., Makarim, F. R., & Aldiosta, P. H. (2023). Intracavernous Stem Cell Injection for Erectile Dysfunction: Safety and Efficacy Review. International Journal of Cell and Biomedical Science. https://doi.org/10.59278/cbs.v2i4.28

Vancouver

Lubis AS, Makarim FR, Aldiosta PH. Intracavernous Stem Cell Injection for Erectile Dysfunction: Safety and Efficacy Review. International Journal of Cell and Biomedical Science. 2023. doi:10.59278/cbs.v2i4.28

BibTeX
@article{Lubis2023,
  author = {Lubis, Ahmad Sulaiman and Makarim, Fadhli Rizal and Aldiosta, Pradipta Hadyan},
  title = {Intracavernous Stem Cell Injection for Erectile Dysfunction: Safety and Efficacy Review},
  journal = {International Journal of Cell and Biomedical Science},
  year = {2023},
  doi = {10.59278/cbs.v2i4.28}
}
Kostenlos starten →